Teitelbaum SL - Search Results

1

Antagonizing Integrin β3 Increases Immunosuppression in Cancer.

Su X, Esser AK, Amend SR, Xiang J, Xu Y, Ross MH, Fox GC, Kobayashi T, Steri V, Roomp K, Fontana F, Hurchla MA, Knolhoff BL, Meyer MA, Morgan EA, Tomasson JC, Novack JS, Zou W, Faccio R, Novack DV, Robinson SD, Teitelbaum SL, DeNardo DG, Schneider JG, Weilbaecher KN. Su X, et al. Among authors: teitelbaum sl. Cancer Res. 2016 Jun 15;76(12):3484-95. doi: 10.1158/0008-5472.CAN-15-2663. Epub 2016 May 23. Cancer Res. 2016. PMID: 27216180 Free PMC article.

2

Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts.

McHugh KP, Hodivala-Dilke K, Zheng MH, Namba N, Lam J, Novack D, Feng X, Ross FP, Hynes RO, Teitelbaum SL. McHugh KP, et al. Among authors: teitelbaum sl. J Clin Invest. 2000 Feb;105(4):433-40. doi: 10.1172/JCI8905. J Clin Invest. 2000. PMID: 10683372 Free PMC article.

3

A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function.

Feng X, Novack DV, Faccio R, Ory DS, Aya K, Boyer MI, McHugh KP, Ross FP, Teitelbaum SL. Feng X, et al. Among authors: teitelbaum sl. J Clin Invest. 2001 May;107(9):1137-44. doi: 10.1172/JCI12040. J Clin Invest. 2001. PMID: 11342577 Free PMC article.

4

c-Fms and the alphavbeta3 integrin collaborate during osteoclast differentiation.

Faccio R, Takeshita S, Zallone A, Ross FP, Teitelbaum SL. Faccio R, et al. Among authors: teitelbaum sl. J Clin Invest. 2003 Mar;111(5):749-58. doi: 10.1172/JCI16924. J Clin Invest. 2003. PMID: 12618529 Free PMC article.

5

Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin.

Faccio R, Novack DV, Zallone A, Ross FP, Teitelbaum SL. Faccio R, et al. Among authors: teitelbaum sl. J Cell Biol. 2003 Aug 4;162(3):499-509. doi: 10.1083/jcb.200212082. J Cell Biol. 2003. PMID: 12900398 Free PMC article.

6

The IkappaB function of NF-kappaB2 p100 controls stimulated osteoclastogenesis.

Novack DV, Yin L, Hagen-Stapleton A, Schreiber RD, Goeddel DV, Ross FP, Teitelbaum SL. Novack DV, et al. Among authors: teitelbaum sl. J Exp Med. 2003 Sep 1;198(5):771-81. doi: 10.1084/jem.20030116. Epub 2003 Aug 25. J Exp Med. 2003. PMID: 12939342 Free PMC article.

7

High dose M-CSF partially rescues the Dap12-/- osteoclast phenotype.

Faccio R, Zou W, Colaianni G, Teitelbaum SL, Ross FP. Faccio R, et al. Among authors: teitelbaum sl. J Cell Biochem. 2003 Dec 1;90(5):871-83. doi: 10.1002/jcb.10694. J Cell Biochem. 2003. PMID: 14624447

8

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

Wang MW, Wei S, Faccio R, Takeshita S, Tebas P, Powderly WG, Teitelbaum SL, Ross FP. Wang MW, et al. Among authors: teitelbaum sl. J Clin Invest. 2004 Jul;114(2):206-13. doi: 10.1172/JCI15797. J Clin Invest. 2004. PMID: 15254587 Free PMC article.

9

Marrow stromal cells and osteoclast precursors differentially contribute to TNF-alpha-induced osteoclastogenesis in vivo.

Kitaura H, Sands MS, Aya K, Zhou P, Hirayama T, Uthgenannt B, Wei S, Takeshita S, Novack DV, Silva MJ, Abu-Amer Y, Ross FP, Teitelbaum SL. Kitaura H, et al. Among authors: teitelbaum sl. J Immunol. 2004 Oct 15;173(8):4838-46. doi: 10.4049/jimmunol.173.8.4838. J Immunol. 2004. PMID: 15470024

10

Vav3 regulates osteoclast function and bone mass.

Faccio R, Teitelbaum SL, Fujikawa K, Chappel J, Zallone A, Tybulewicz VL, Ross FP, Swat W. Faccio R, et al. Among authors: teitelbaum sl. Nat Med. 2005 Mar;11(3):284-90. doi: 10.1038/nm1194. Epub 2005 Feb 13. Nat Med. 2005. PMID: 15711558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

554 results

Search Page

Filters